secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001641172-25-024172
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity closes $1.45M capital raise and reclassifies warrants adding $2.8M to equity
--------------------------------------------------------------------------------

- Private placement of 990 Series B Preferred shares convertible into ~4.3M common at $0.23/sh and warrants for ~6.7M shares at $0.352/sh, gross proceeds ~$1.2M.
- Warrant inducement: existing warrants exercised at reduced $0.23/sh for $253K cash; new warrants for 1.43M shares at $0.352/sh pending stockholder approval.
- Warrant amendment reclassifies May 2025 warrants from liability to equity, increasing stockholders' equity by ~$2.8M.
- Anti-dilution adjustment on May 2025 warrants reduces exercise price to $0.23/sh and increases shares issuable by ~8M.
- Authorized common shares increased from 100M to 350M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000164117225024172/0001641172-25-024172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000164117225024172/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-024172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer